13.09.2015 Views

NOTE AIFA 2004

NOTE AIFA 2004 - ASL n. 1 Imperiese

NOTE AIFA 2004 - ASL n. 1 Imperiese

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>NOTE</strong> <strong>AIFA</strong> <strong>2004</strong><br />

10. Perrillo R, et al. Multicenter study of Lamivudine therapy for hepatitis B after transplantation. Hepatology 1999;29:1581-<br />

6.<br />

11. Mutimer DJ, et al. Lamivudine without HBIG for prevention of graft infection by hepatitis B; long term follow up.<br />

Hepatology 1999;30:301.<br />

12. Angus PW, et al. Combination low dose Hepatitis B Immune Globulin (HBIG) and Lamivudine therapy provides effective<br />

prophylaxis against post transplant hepatitis B. Hepatology 1999;30:301.<br />

13. Lau DTY, et al. Lamivudine for chronic delta hepatitis. Hepatology 1999;30:546-9.<br />

SPECIALITÀ MEDICINALI<br />

PRINCIPIO ATTIVO LAMIVUDINA J05AF05<br />

FARMACO CONFEZIONE AIC DITTA<br />

ZEFFIX 100 MG 28 COMPRESSE 34506016 GLAXO GROUP<br />

FILMRIVESTITE IN BLISTER USO<br />

LIMITED<br />

ORALE<br />

ZEFFIX 5 MG/ML SOLUZIONE ORALE 1 34506030 GLAXO GROUP<br />

FLACONE 240 ML USO ORALE<br />

LIMITED<br />

50

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!